{"id":504632,"date":"2026-01-09T21:34:20","date_gmt":"2026-01-09T21:34:20","guid":{"rendered":"https:\/\/www.europesays.com\/us\/504632\/"},"modified":"2026-01-09T21:34:20","modified_gmt":"2026-01-09T21:34:20","slug":"amazon-adds-novo-nordisks-wegovy-pill-to-pharmacy-platform","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/504632\/","title":{"rendered":"Amazon Adds Novo Nordisk&#8217;s Wegovy Pill to Pharmacy Platform"},"content":{"rendered":"\n<p class=\"yf-vbsvxt\">This article first appeared on <a href=\"https:\/\/www.gurufocus.com\/news\/4104037\/amazon-adds-novo-nordisks-wegovy-pill-to-pharmacy-platform?utm_source=yahoo_finance&amp;utm_medium=syndication&amp;utm_campaign=headlines&amp;r=caf6fe0e0db70d936033da5461e60141\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:GuruFocus;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">GuruFocus<\/a>.<\/p>\n<p class=\"yf-vbsvxt\">Amazon Pharmacy (<a href=\"https:\/\/finance.yahoo.com\/quote\/AMZN\" data-ylk=\"slk:AMZN;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" target=\"_blank\" rel=\"noopener\">AMZN<\/a>, <a href=\"https:\/\/finance.yahoo.com\/quote\/AMZN\" data-ylk=\"slk:Financials;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" target=\"_blank\" rel=\"noopener\">Financials<\/a>) stated that it is now selling Novo Nordisk&#8217;s (<a href=\"https:\/\/finance.yahoo.com\/quote\/NVO\" data-ylk=\"slk:NVO;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" target=\"_blank\" rel=\"noopener\">NVO<\/a>, <a href=\"https:\/\/finance.yahoo.com\/quote\/NVO\" data-ylk=\"slk:Financials;elm:context_link;itc:0;sec:content-canvas\" class=\"link \" target=\"_blank\" rel=\"noopener\">Financials<\/a>) Wegovy weight loss <a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/amazon-pharmacy-offers-novo-nordisks-wegovy-pill-2026-01-09\/\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:medication via both insurance programs and a cash pay option;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">medication via both insurance programs and a cash pay option<\/a>. The new choice adds to Amazon&#8217;s digital health services as the need for obesity treatments keeps growing.<\/p>\n<p class=\"yf-vbsvxt\">People with commercial insurance may only have to pay $25 a month, while people without insurance may get the medicine for as low as $149 a month. The business added that in the next several weeks, Amazon Pharmacy kiosks would also provide the pill form of Wegovy.<\/p>\n<p class=\"yf-vbsvxt\">In December, the U.S. Food and Drug Administration authorized Novo Nordisk&#8217;s 25-milligram Wegovy tablet. Semaglutide is the active ingredient in the oral version of Wegovy and Ozempic, just as it is in the injectable forms.<\/p>\n<p class=\"yf-vbsvxt\">Amazon&#8217;s recent step boosts its position in the quickly rising online prescription business and fits with the larger trend of using technology to provide healthcare.<\/p>\n","protected":false},"excerpt":{"rendered":"This article first appeared on GuruFocus. Amazon Pharmacy (AMZN, Financials) stated that it is now selling Novo Nordisk&#8217;s&hellip;\n","protected":false},"author":3,"featured_media":425289,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[2431,226103,2026,17970,210,1141,1142,9412,67,132,68],"class_list":{"0":"post-504632","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-care","8":"tag-amazon","9":"tag-commercial-insurance","10":"tag-financials","11":"tag-gurufocus","12":"tag-health","13":"tag-health-care","14":"tag-healthcare","15":"tag-novo-nordisk","16":"tag-united-states","17":"tag-unitedstates","18":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115867291627722349","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/504632","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=504632"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/504632\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/425289"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=504632"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=504632"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=504632"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}